Affimed N.V.
Affimed N.V. (AFMD) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
afmd · stock forecast · 11 analysts (3M) · FMP · updated Feb 12, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$10.00
Consensus
$7.50
+4032.2% upside
Low
$5.00
Median: $7.5 · Last Close: $0.18
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.18 | ↑ 0.00% |
1-day model range: $0.18–$0.18. Peak: $0.18 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AFMD · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-05-14 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-05-13 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2025-05-13 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-12-12 | Wells Fargo | Maintains | Overweight→Overweight |
| 2024-12-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | Stifel | Maintains | Hold→Hold |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-09-25 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-09-12 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Affimed N.V. (AFMD) stock. Of the recent 34 rating actions, 1 were upgrades and 6 were downgrades. 11 analysts currently cover AFMD.
Analyst Recommendation Trends
AFMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 34.9% YoY
Revenue Next Year
$2M
↑ 11.1% YoY
EPS This Year
$-1.74
EPS Next Year
$-1.37
↓ 21.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast AFMD EPS of $-1.74 for the current fiscal year, based on estimates from 2 analysts. The AFMD revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AFMD stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AFMD price target is $7.50 (+4032.2% upside), with an analyst consensus of Buy.
The AFMD short-term stock prediction for tomorrow is $0.18 (+0.00%).
Affimed N.V. trades on NASDAQ under the ticker AFMD. The AFMD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 55% of covering analysts.
Frequently asked questions
AFMD forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month AFMD price target is $7.50, with a high forecast of $10.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +4032.2% potential upside from the current price of $0.18.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.